loading
前日終値:
$5.15
開ける:
$5.09
24時間の取引高:
322.47K
Relative Volume:
1.45
時価総額:
$209.27M
収益:
-
当期純損益:
$-19.90M
株価収益率:
-9.2075
EPS:
-0.53
ネットキャッシュフロー:
$-19.80M
1週間 パフォーマンス:
+24.17%
1か月 パフォーマンス:
+30.83%
6か月 パフォーマンス:
-22.54%
1年 パフォーマンス:
+33.70%
1日の値動き範囲:
Value
$4.88
$5.16
1週間の範囲:
Value
$3.88
$5.25
52週間の値動き範囲:
Value
$3.19
$6.8184

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
名前
Diamedica Therapeutics Inc
Name
セクター
Healthcare (1161)
Name
電話
(763) 496-5454
Name
住所
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
職員
28
Name
Twitter
@diamedica
Name
次回の収益日
2025-03-17
Name
最新のSEC提出書
Name
DMAC's Discussions on Twitter

DMAC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
4.88 197.26M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-07 開始されました H.C. Wainwright Buy
2024-04-24 再開されました Craig Hallum Buy
2023-06-22 アップグレード Oppenheimer Perform → Outperform
2021-04-09 開始されました Oppenheimer Outperform
2021-02-17 開始されました ROTH Capital Buy
2020-10-30 開始されました Guggenheim Buy
2020-07-08 開始されました Maxim Group Buy
2019-04-30 開始されました Dougherty & Company Buy
2019-03-05 開始されました Lake Street Buy
すべてを表示

Diamedica Therapeutics Inc (DMAC) 最新ニュース

pulisher
01:25 AM

DiaMedica Therapeutics Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia

01:25 AM
pulisher
Jul 24, 2025

Is DiaMedica Therapeutics Inc. stock overhyped or has real potentialBreakthrough financial growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

DiaMedica raises $30.1M in private placement for preeclampsia, stroke treatment - The Business Journals

Jul 24, 2025
pulisher
Jul 24, 2025

The Beat: Entrust names new CEO, DiaMedica raises millions - The Business Journals

Jul 24, 2025
pulisher
Jul 24, 2025

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

DiaMedica Therapeutics Secures $30.1 Million in Private Placement - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement - Investing.com India

Jul 23, 2025
pulisher
Jul 22, 2025

Is DiaMedica Therapeutics Inc. a good long term investmentDynamic profit expansion - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives DiaMedica Therapeutics Inc. stock priceExtraordinary market timing - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about DiaMedica Therapeutics Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Diamedica Therapeutics shares rise 11.01% intraday after $30.1M private placement and positive trial results for DM199 in preeclampsia. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica Announces $30.1M Private Placement for DM199 - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline - Business Wire

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $12.00 - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

DiaMedica shares drop 35% following InvestingPro’s overvalued warning By Investing.com - Investing.com India

Jul 20, 2025
pulisher
Jul 19, 2025

DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

What makes DiaMedica Therapeutics Inc. stock price move sharplyReliable High Profit Alerts - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

DiaMedica stock price target raised to $12 from $10 at H.C. Wainwright - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer - BioSpace

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica Therapeutics reports interim results from DM199 study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica Announces Positive Interim Results for DM199 Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica reports positive interim results for preeclampsia treatment - Investing.com

Jul 17, 2025
pulisher
Jul 15, 2025

Why DiaMedica Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How DiaMedica Therapeutics Inc. stock performs during market volatilityValue Pick Scanner - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st

Jul 15, 2025
pulisher
Jul 01, 2025

Trend Tracker for (DMAC) - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 30, 2025

DiaMedica Therapeutics Inc.(NasdaqCM: DMAC) added to Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

DiaMedica Therapeutics Inc.(NasdaqCM: DMAC) added to Russell 3000 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 24, 2025

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - Business Wire

Jun 24, 2025
pulisher
Jun 14, 2025

DiaMedica Therapeutics Insiders Up US$4.1m On US$9.00m Investment - simplywall.st

Jun 14, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Increases Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

42,212 Shares in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Purchased by Jane Street Group LLC - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Can DiaMedica Deliver A Breakthrough In Preeclampsia Treatment? - RTTNews

Jun 04, 2025

Diamedica Therapeutics Inc (DMAC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):